Homology Medicines, Inc. Profile Avatar - Palmy Investing

Homology Medicines, Inc.

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus ve…

Biotechnology
US, Bedford [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Homology Medicines, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of FIXX's Analysis
CIK: 1661998 CUSIP: 438083107 ISIN: US4380831077 LEI: - UEI: -
Secondary Listings
FIXX has no secondary listings inside our databases.